The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The Food and Drug Administration has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to ...

Pfizer's robust product pipeline and consistent R&D investments position it well for future growth. See why I rate PFE stock ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

In a February 28th response, Mr Martin told Pfizer that he recognised the important role the industry played in Ireland. EU states remained “divided” on the proposed changes to the period of ...

Pfizer posts mixed first-quarter results ... Washington has launched an investigation into the industry, laying the groundwork for possible levies. Bourla in an interview said the industry ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

PFE also trades at a noticeable discount to the benchmark S&P 500’s 21.3X forward earnings multiple and its Zacks industry average of 16.4X. At current levels, Pfizer’s annual dividend also ...